Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Curcumin vs Triamcinolone for Oral Lichen Planus
NCT06605911Phase 3Completed
- Start
- Jun 2023
- Primary completion
- Aug 2023
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of curcumin in oral lichen planus (OLP) (3 arms). Primary endpoints: Visual Analog Scale at 3 months and Oral Disease Severity Score at 3 months. Started Jun 2023; status: completed.
02
Drugs
curcumin
03
Conditions
oral lichen planus (OLP)
Beyond the preview
Go deeper on NCT06605911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06605911.